Study on Sotrovimab and Its Impact on the Immune Response to COVID-19 Infection in Real-life in the UAE and Bahrain
Clinical trial NCT05398718 · UNKNOWN
Trial details
- NCT number
- NCT05398718
- Sponsor
- Abu Dhabi Health Services Company
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-05-12
- Primary completion
- 2022-12-15
- Enrollment
- 20000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.